Hyperthermic and lethal effects of methamphetamine: Roles of dopamine D1 and D2 receptors

Neuroscience Letters

Volumn 438, Issue 3, 2008, Pages 327-329

  Ito, Miki ^a   Numachi, Yohtaro ^a   Ohara, Arihisa ^a   Sora, Ichiro ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Body temperature; Knockout mice

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DRUG EFFECT; FEVER; HYPERTHERMIA; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; BODY TEMPERATURE; FEVER; LETHAL DOSE 50; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; TIME FACTORS;

EID: 44349177395     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.04.034     Document Type: Article

References (19)

1. Albers D.S., and Sonsalla P.K. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J. Pharmacol. Exp. Ther. 275 (1995) 1104-1114
2. Bowyer J.F., Davies D.L., Schmued L., Broening H.W., Newport G.D., Slikker Jr. W., and Holson R.R. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268 (1994) 1571-1580
3. Bowyer J.F., Tank A.W., Newport G.D., Slikker Jr. W., Ali S.F., and Holson R.R. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J. Pharmacol. Exp. Ther. 260 (1992) 817-824
4. Broening H.W., Morford L.L., and Vorhees C.V. Interactions of dopamine D1 and D2 receptor antagonists with d-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions. Synapse 56 (2005) 84-93
5. Bronstein D.M., and Hong J.S. Effects of sulpiride and SCH 23390 on methamphetamine-induced changes in body temperature and lethality. J. Pharmacol. Exp. Ther. 274 (1995) 943-950
6. Davidson C., Gow A.J., Lee T.H., and Ellinwood E.H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Brain Res. Rev. 36 (2001) 1-22
7. Derlet R.W., Albertson T.E., and Rice P. Antagonism of cocaine, amphetamine, and methamphetamine toxicity. Pharmacol. Biochem. Behav. 36 (1990) 745-749
8. Derlet R.W., Albertson T.E., and Rice P. The effect of SCH 23390 against toxic doses of cocaine, d-amphetamine and methamphetamine. Life Sci. 47 (1990) 821-827
9. Funahashi M., Kohda H., Hori O., Hayashida H., and Kimura H. Potentiating effect of morphine upon d-methamphetamine-induced hyperthermia in mice. Effects of naloxone and haloperidol. Pharmacol. Biochem. Behav. 36 (1990) 345-350
10. He J., Xu H., Yang Y., Zhang X., and Li X.M. Neuroprotective effects of olanzapine on methamphetamine-induced neurotoxicity are associated with an inhibition of hyperthermia and prevention of Bcl-2 decrease in rats. Brain Res. 1018 (2004) 186-192
11. Iorio L.C., Barnett A., Leitz F.H., Houser V.P., and Korduba C.A. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J. Pharmacol. Exp. Ther. 226 (1983) 462-468
12. Kalant H., and Kalant O.J. Death in amphetamine users: causes and rates. Can. Med. Assoc. J. 112 (1975) 299-304
13. LaVoie M.J., and Hastings T.G. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J. Neurosci. 19 (1999) 1484-1491
14. Namiki M., Mori T., Sawaguchi T., Ito S., and Suzuki T. Underlying mechanism of combined effect of methamphetamine and morphine on lethality in mice and therapeutic potential of cooling. J. Pharmacol. Sci. 99 (2005) 168-176
15. Seiden L.S., Sabol K.E., and Ricaurte G.A. Amphetamine: effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 33 (1993) 639-677
16. Uchima E., Ogura Y., Hiraga Y., and Shikata I. Relationship between methamphetamine toxicity and catecholamine levels in heart and brain of mice. Nihon Hoigaku Zasshi 37 (1983) 198-208
17. Witkin J.M., Goldberg S.R., and Katz J.L. Lethal effects of cocaine are reduced by the dopamine-1 receptor antagonist SCH 23390 but not by haloperidol. Life Sci. 44 (1989) 1285-1291
18. Xu W., Zhu J.P., and Angulo J.A. Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors. Synapse 58 (2005) 110-121
19. Yuan J., Hatzidimitriou G., Suthar P., Mueller M., McCann U., and Ricaurte G. Relationship between temperature, dopaminergic neurotoxicity, and plasma drug concentrations in methamphetamine-treated squirrel monkeys. J. Pharmacol. Exp. Ther. 316 (2006) 1210-1218